All Work

Chris Lange

6 Top Oil and Gas Stocks Analysts Want You to Buy

The week of September 12 brought a fair number analyst upgrades and downgrades in oil and gas stocks. Some analysts believe many of the energy stocks continue to be very smart buys, based on…

Chris Lange · 10 years ago

VimpelCom Prices Secondary Offering

VimpelCom intends to offer more than 142 million shares at $3.50 apiece, in a secondary offering valued up to more than $573 million.

Chris Lange · 10 years ago

Oracle Stumbles Despite Cloud Growth

After Oracle reported its fiscal first-quarter financial results after the markets closed on Thursday, this networking giant's shares slipped in the after-hours session.

Chris Lange · 10 years ago

Has AcelRx Pharmaceuticals Hit a Home Run?

Shares of AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX) surged following positive results from a late-stage trial. The company announced the outcome of an open-label Phase 3 trial (SAP303) of investigational product candidate ARX-04. Let us just say, it…

Chris Lange · 10 years ago

Why This Goodyear Dividend Hike Could Get Even Larger

Goodyear Tire & Rubber has announced its updated financial performance targets and a solid dividend hike, as increasing demand for larger, more profitable tires has boosted the business.

Chris Lange · 10 years ago

Philly Fed Survey Sees Manufacturing on the Rise

The Philly Fed Survey signaled that manufacturing conditions continued to improve, with positive indicators for general activity and new orders increasing from their August numbers.

Chris Lange · 10 years ago

Why Aeri Pharma Won So Big on a Single Trial

Shares of Aeri Pharmaceuticals skyrocketed early Thursday after the company issued positive results on its intraocular pressure (IOP) treatment in patients with glaucoma.

Chris Lange · 10 years ago

Why This FDA Departure Is Huge for Sarepta

Sarepta Therapeutics closed out Wednesday with its shares up over 25% following positive developments surrounding eteplirsen, its treatment of Duchenne muscular dystrophy.

Chris Lange · 10 years ago

What to Expect From Oracle Earnings

Oracle Corp. (NYSE: ORCL) is scheduled to report its fiscal first-quarter financial results after markets close on Thursday. The consensus estimates from Thomson Reuters are calling for $0.58 in earnings per share (EPS) and…

Chris Lange · 10 years ago

Jeld-Wen Prepares for IPO

Jeld-Wen Holding has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).

Chris Lange · 10 years ago

Will Carl Icahn Take Herbalife Private?

Carl Icahn believes that Herbalife might be better off as a privately held firm and he has weighed the possibility of launching a tender offer for it.

Chris Lange · 10 years ago

At Home Scores on Q2 Earnings

At Home Group reported its fiscal second-quarter financial results after the markets closed on Tuesday, and shares rallied early Wednesay.

Chris Lange · 10 years ago

Agios Files for Secondary Offering

Agios Pharmaceuticals has filed with the SEC regarding a secondary offering of up to $150 million of its common stock.

Chris Lange · 10 years ago